Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
DexCom (DXCM) PT Raised to $150 at Canaccord Genuity
-
DexCom Announces Upcoming Conference Presentation
-
DexCom (DXCM) PT Raised to $105 at Canaccord Genuity
-
DexCom (DXCM) PT Raised to $85 at Canaccord Genuity
-
DexCom (DXCM) PT Raised to $81 at Canaccord Genuity
-
DexCom (DXCM) PT Raised to $80 at Canaccord Genuity; 'G6 to be a driver starting in Q2/18'
-
DexCom (DXCM) PT Lowered to $69 at Canaccord Genuity
-
Canaccord Genuity Reiterates Buy on DexCom (DXCM) Following FDA Approval of DexCom's G5 Mobile
-
DexCom Announces Upcoming Conference Presentations
-
Pre-Open Stock Movers 04/30: (GLUU) (CKSW) (WX) Higher; (YELP) (INO) (HAR) Lower (more...)
-
Canaccord Genuity Calls DexCom (DXCM) Quarter Solid, Says Momentum Building
-
Canaccord Genuity Reiterates a 'Buy' on DexCom (DXCM); Management Shines Light on '12 Catalysts